• 1
    Arrabal Martin M, Fernandez Rodriguez A, Arrabal Polo MA, Ruiz Garcia MJ, Zuluaga Gomez A. Study of the physical-chemical factors in patients with renal lithiasis. Arch Esp Urol 2006; 59: 583594
  • 2
    Amaro CR, Goldberg J, Amaro JL, Padovani CR. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005; 31: 2933
  • 3
    Netelenbos JC, Zwijnenburg PJ, ter Wee PM. Risk factors determining active urinary stone formation in patients with urolithiasis. Clin Nephrol 2005; 63: 188192
  • 4
    Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U. Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology 2010; 76: 238241
  • 5
    Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 2000; 164: 162165
  • 6
    Simic-Ogrizovic S, Dopsaj V, Jovicic S, Milenkovic D, Jovanovic D, Nesic V. The most important factor for active urinary stone formation in patients with urolithiasis. Med Pregl 2007; 60: 117120
  • 7
    Chandhoke PS. Evaluation of the recurrent stone former. Urol Clin North Am 2007; 34: 315322
  • 8
    Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 2011; 108: 19031908
  • 9
    Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin North Am 2007; 34: 323334
  • 10
    Hosseini MM, Eshraghian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol 2010; 42: 127131
  • 11
    Mithani S, Zaidi Z. Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls. J Pak Med Assoc 2005; 55: 371373
  • 12
    DeFoor WR, Jackson E, Minevich E et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology 2010; 76: 242246
  • 13
    Batista Peres LA, Sella Langer S, Schmidt RC et al. Nephrolithiasis in pediatric patients: metabolic and anatomical investigation. J Bras Nefrol 2011; 33: 3438
  • 14
    Hofbauer J, Höbarth K, Zechner O. The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi. Z Urol Nephrol 1990; 83: 597602
  • 15
    Höbarth K, Hofbauer J. Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis. Eur Urol 1991; 19: 165168
  • 16
    Pak CYC, Peterson RD, Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol 2002; 168: 3134
  • 17
    Caudarella R, Vescini F, Buffa A, Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front Biosci 2003; 8: s10841086
  • 18
    Giannini S, Nobile N, Sartori L et al. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 1998; 50: 94100
  • 19
    Caudarella R, Vescini F, Buffa A et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003; 16: 260266
  • 20
    Audran M, Bataille P, Sebert JL et al. Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X-ray computed tomography and histomorphometry. Rev Rhum Mal Osteoartic 1991; 58: 747750
  • 21
    Zanchetta JR, Rodriguez G, Negri AL, del Valle E, Spivacow FR. Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 1996; 73: 557560
  • 22
    Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994; 9: 15251532